Anemia is a condition characterized by a deficiency in red blood cells or hemoglobin, which affects the body's ability to deliver oxygen to its tissues. This common healthcare issue can have several underlying causes, such as iron deficiency, vitamin B12 or folate deficiencies, chronic diseases like kidney failure or rheumatoid arthritis, and even genetic disorders. The symptoms of anemia can vary depending on its type and severity but often include fatigue, shortness of breath, dizziness, pale skin coloration, rapid heartbeat, or irregular heart rhythm. To diagnose anemia accurately and determine its cause precisely, doctors may perform blood tests measuring red blood cell count and hemoglobin levels alongside other diagnostic investigations. Treatment for anemia depends on the root cause but typically involves dietary changes with increased intake of iron-rich foods (such as leafy greens and lean meats), oral supplements like iron tablets or injections when necessary, and addressing any underlying conditions that contribute to this health concern.
1.
enhancing survivors of brain tumors' quality of life.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
A protein with new anticancer activity has been identified
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
3.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
4.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
5.
Progressive Strategies in Oncology and Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Managing Common Side Effects During Cancer Treatment
5.
Clinical Insights in Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation